| Up
2004P-0520:
180-DAY EXCLUSIVITY FOR IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE
INHALATION SOLUTION
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 11/22/2004
|
| 11/22/2004
|
| Private Industry
|
| IVAX Pharmaceuticals,
Inc.
|
|
|
|
|
|
|
| pdf,
Attachment
|
|
|
|
|
| Signature:
|
| David G. Adams
|
|
|
|
|
| ACK1
|
| 11/22/2004
|
| 11/22/2004
|
| Federal
Government
|
| HFA-305 to IVAX Pharmaceuticals,
Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| Jennie C. Butler
|
|
|
|
|
|
|
|
| CR1
|
| 11/29/2004
|
| 11/29/2004
|
| Federal
Government
|
| HFA-305 to Venable,
LLP
|
|
|
|
|
|
|
| pdf
|
| Correction of ACK
1
|
|
|
|
| Signature:
|
| Jennie C Butler
|
|
|
|
|
|
|
|
| C1
|
| 12/20/2004
|
| 12/17/2004
|
| Drug Industry
|
| Eon Labs
|
|
|
|
|
|
|
| pdf
Enclosure
A
Enclosure
B
|
|
|
|
|
| Signature:
|
| Shashank Upadhye, Esq
|
|
|
|
|
| C2
|
| 01/31/2005
|
| 01/31/2005
|
| Private Industry
|
| Dey, L.P. (Dey)
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Michelle A. Carpenter, J.D.
|
|
|
| RC1
|
| 02/28/2005
|
| 02/25/2005
|
| Drug Industry
|
| IVAX Pharmaceuticals,
Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| David G. Adams
|
|
|
|
|
| EMC1
|
| 04/01/2005
|
| 04/01/2005
|
| Drug Industry
|
| Eon Labs, Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Shashank Upadhye, Esq
|
|
|
|
|
| LET1
|
| 05/20/2005
|
| 05/20/2005
|
| Federal
Government
|
| HFD-005 to Venable,
LLP
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| Jane A. Axelrad
|
|
|
| |
Top
| Up
Page last updated
June 1, 2005
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |
